Back to User profile » Dr Chengping Hu
Papers published by Dr Chengping Hu:
The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion
Gu Q, Deng X, Li Z, Wang J, Hu C, Lei S, Cai X
International Journal of General Medicine 2021, 14:1429-1435
Published Date: 20 April 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
Chen F, Gu Q, Hu C, Cai X, Lei S
OncoTargets and Therapy 2019, 12:3321-3325
Published Date: 1 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy
Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H, Tang Y, Cao L, Lu R
Cancer Management and Research 2019, 11:2425-2439
Published Date: 27 March 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report
Zhang Y, He B, Zhou D, Li M, Hu C
OncoTargets and Therapy 2019, 12:51-56
Published Date: 18 December 2018
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/IIG8Om9qlkc/1.jpg)
Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C
OncoTargets and Therapy 2018, 11:8575-8587
Published Date: 30 November 2018
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/PrlTJItshQo/1.jpg)
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study
Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ
Cancer Management and Research 2018, 10:1927-1934
Published Date: 6 July 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
Chen JH, Wu S, Hu C, Yang Y, Rajan N, Chen Y, Yang C, Li J, Chen W
ClinicoEconomics and Outcomes Research 2016, 8:97-111
Published Date: 26 April 2016